Cell-based tissue-engineered products

A further committee. The Committee for Advance Therapies, is to be established under regulation (EC) No. 1394/2007 to deal with issues raised by emerging drug products based on gene therapy, somatic cell therapy and tissue engineering. 

Tissue- or cell-engineered products represent a small but significant subgroup of cell-based products. Such products also consist of/contain fully differentiated cells but do undergo some... 

Animal-based products Marine-based products Tissue engineering Cell therapy Virology Formulations Liposomes/Polymers Biosimilars (Biogenerics)... 

Abstract Polyhydroxyalkanoate (PHA) is a plastic-like material synthesized by many bacteria. PHA serves as an energy and carbon storage componnd for the bacteria. PHA can be extracted and purified from the bacterial cells and the resulting product resembles some commodity plastics such as polypropylene. Because PHA is a microbial product, there are natural enzymes that can degrade and decompose PHA. Therefore, PHA is an attractive material that can be developed as a bio-based and biodegradable plastic. In addition, PHA is also known to be biocompatible and can be used in medical devices and also as bioresorbable tissue engineering scaffolds. In this chapter, a brief introduction about PHA and the fermentation feedstock for its production are given. 

---